HSandM Magazine

Menu
  • Home
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
  • Advertise
  • Agency Directory
  • Showcase your Innovations
  • FREE SUBSCRIPTION!
Menu

HSandM Magazine

Search

Dec/Jan2018

Latest stories

Cleveland Clinic

How Novartis Built a Stronger Brand in MS Therapy

INDUSTRY TRENDS: BY THE NUMBERS

More stories

  • in Top Industry Lists

    HS&M TOP LISTS

    by hsandm December 1, 2017, 12:00 pm

  • in Industry Trends

    What If Digital Could Drive Revenue?

    by hsandm December 1, 2017, 12:00 pm

  • in Motivideos

    MOTIVIDEOS

  • in Why I Work in Healthcare

    Why I Work In Healthcare

    by hsandm December 1, 2017, 12:00 pm

  • in Executive Spotlight

    She launched Lipitor at Pfizer, and drove $4B at AstraZeneca. What will she do for Mylan?

    by hsandm December 1, 2017, 12:00 pm

  • in Great Minds

    Great Advice from Great Minds: Success Secrets from Michael Tremblay, President of Astellas Pharma Canada

    by hsandm December 1, 2017, 12:00 pm

  • in Innovation Showcase

    More Effective Creative for Teva and Syneron

    by hsandm December 1, 2017, 12:00 pm

  • in Round Table

    Containing Costs: How We’re All Involved

    by hsandm December 1, 2017, 12:00 pm

Trending Now

  • Headlines

    192 Views0 Comments

    in Headlines

    ICON to acquire PRA Health Sciences

    Dublin, Ireland, 24th February 2021- ICON plc, (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, and government and public health organisations, today announced it has entered into a definitive agreement to acquire PRA Health Sciences, Inc. (NASDAQ: PRAH) in a cash and stock transaction valued at approximately $12 billion, with the per share merger consideration consisting of $80 in cash and 0.4125 shares of ICON stock. The consideration represents an approximately 30% premium to PRA’s closing price as of February 23rd, 2021. More

    by hsandm February 24, 2021, 8:39 pm

    Read More

  • Headlines

    899 Views0 Comments

    in Headlines

    Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition

    Wilmington, MA , February 17 2021 (Business Wire) — Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a definitive agreement to acquire Cognate BioServices, Inc., a premier, cell and gene therapy contract development and manufacturing organization (CDMO), for approximately $875 million in cash, subject to customary closing adjustments. The transaction is expected to close by the end of the first quarter of 2021, subject to regulatory requirements and customary closing conditions. More

    by hsandm February 17, 2021, 7:13 pm

    Read More

  • Headlines

    517 Views0 Comments

    in Headlines

    Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs

    San Francisco, CA, February 17, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the completion of a $60 million financing. The proceeds will be used to advance Excision’s lead candidate, EBT-101, into a Phase 1/2 clinical trial in patients with chronic HIV infection. The financing will also support preclinical programs including EBT-103 targeting JC Virus for Progressive Multifocal Leukoencephalopathy (PML), EBT-104 for Herpes Simplex Virus, and EBT-107 for Hepatitis B. More

    by hsandm February 17, 2021, 6:51 pm

    Read More

  • Headlines

    1 Shares777 Views0 Comments

    in Headlines

    Henry Schein One Appoints New Chief Executive Officer

    American Fork, UT, February 16, 2021 (BUSINESS WIRE) — Henry Schein One, a joint venture of Henry Schein, Inc., and Internet Brands, has announced that Mike Baird will assume the role of Chief Executive Officer, leading all aspects of Henry Schein One’s business. In his new role of CEO, Mr. Baird will lead the organization in driving growth, developing more seamlessly integrated products, and advancing digital innovations that help customers build stronger practices and deliver quality care. More

    by hsandm February 16, 2021, 7:37 pm

    Read More

  • Headlines

    1.1k Views0 Comments

    in Headlines

    Boehringer Ingelheim Animal Health USA Establishes Pawru, Inc.

    Duluth, GA., February 16, 2021 (PRNewswire) — Boehringer Ingelheim Animal Health USA Inc. today announced the creation of Pawru, Inc. as a separate Company within the Boehringer Ingelheim Animal Health business. More

    by hsandm February 16, 2021, 6:27 pm

    Read More

  • Headlines

    947 Views0 Comments

    in Headlines

    AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock

    New York NY, February 16 2021 (PRNewswire) — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 6,250,000 shares of common stock of the Company at a price to the public of $1.60 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 19, 2021, subject to satisfaction of customary closing conditions. More

    by hsandm February 16, 2021, 6:17 pm

    Read More

Categories

  • Agency Directory
  • Digital Magazine
  • Editorial Board
  • Executive Spotlight
  • Great Minds
  • Headlines
  • Industry Trends
  • Innovation Showcase
  • Leadership
  • Motivideos
  • Round Table
  • Talent Trends
  • Top Industry Lists
  • Uncategorized
  • Why I Work in Healthcare

© 2021 by CL Media, Inc.

  • Home
  • Contact us
  • GDPR Privacy policy
  • Privacy Policy
  • Terms of Use
  • Sign Up!
Back to Top
Close
  • Home
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
  • Advertise
  • Agency Directory
  • Showcase your Innovations
  • FREE SUBSCRIPTION!
  • facebook
  • twitter
  • instagram
  • pinterest
  • youtube

Log In

Sign In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.